Here’s why we stand out as
your ideal partner
High-Quality Documentation
Comprehensive documentation that supports compliance and development.
Consistent Compliance
Unwavering adherence to global regulatory standards.
Rapid Response
Quick and effective solutions to regulatory and quality issues.
Proven IP Protection
Robust protection for your intellectual property.
Streamlined Decision-Making
Efficient organizational structure that speeds up decision-making.
Scalable Capacity
Ready to expand production and build new facilities as your needs grow.
Transparent Dealings
Clear, straightforward communications and transactions.
Faster Turnaround Times
Efficient processes that ensure timely product deliveries.
1
+
Active Clients
1
+
Active Clients
1
+
Active Clients
1
+
Active Clients
1
+
Active Clients
Fulfilling Your Pharmaceutical Needs from
Development to Manufacturing
Saurav Chemicals is equipped to support you with a broad array of products, precise manufacturing capabilities,
and expert guidance tailored to meet your unique needs.
API
CDMO
Intermediates
Vaccine Ingredients
API
Supplying high-quality APIs tailored to your pharmaceutical formulations, ensuring efficacy and safety in every dosage.
Know MoreCDMO
Partnering with you to streamline the development, manufacturing, and testing of pharmaceutical products, ensuring compliance and efficiency from concept to market.
Explore NowIntermediates
Offering a range of intermediates crucial for pharmaceutical synthesis, providing essential building blocks for your drug development processes.
Find Out MoreVaccine Ingredients
Providing essential components for vaccine manufacturing, supporting the production of safe and effective vaccines to protect public health.
Learn MoreOur Milestones and Achievements
1990
First manufacturing facility (for Intermediates) set up in late 90's
2002
Becomes largest supplier of Cephalosporin & Penem Intermediates in India
04-08
API manufacturing site set up First EU GMP Certificaton of API site in 2005, Subsequent approvals in, 2008, 2011, 2012 & 2015
2013
Joint Venture with Mitsubishi Corporation, Japan
2014
SCL receives WHO Geneva GMP approval
2015
AFM registration with PMDA, Japan EU GMP by Danish Medicine, TGA Empanelment
16-18
USFDA Approval in March '16, '17, '18. WHO GENEVA Empanelment KFDA, First CEP received, Purchase of New Greenfield Site
19-21
Second CEP, TGA Empanelment, PMDA approval
2022
SCL ventured into development of Vaccine Ingredients, with proposed pipeline of 25 products
2024
SCL sets up a Knowledge Centre at the Genome Valley in Hyderabad, EDQM certification received
Blogs
Events
Showcasing Our Presence at Major Industry Events Worldwide.